In early announcements, MetLife Inc. (NYSE:MET) declared a quarterly dividend of $0.57 per share and a $3B buyback plan. Major financial groups like J.P. Morgan and Barclays have reaffirmed their buy rating and raised MetLife's price target to $95.00 and $94.00 respectively. Shares of MET are being bought in large numbers by various financial groups and advisory firms. The insurer linked up with Sprout.ai to advance global claims automation. Wall Street expects earnings growth, evidenced by MetLife reporting variable investment income and proceeding with a $10 billion variable annuity risk transfer transaction. A recent announcement sets the spotlight on the introduction of the company's AI-driven online protection tools. The company has also been praised for its digital platform which is anticipated to transform its massive dental network. Looking forward to Q2 2025, MetLife plans to hold a conference call to discuss results. The target price for MetLife is set at $94.17 by market analysts. The company also confirmed increases in its common stock dividend by 4.1%.
Metlife MET News Analytics from Thu, 12 Dec 2024 08:00:00 GMT to Sat, 12 Jul 2025 10:56:55 GMT - Rating 7 - Innovation 3 - Information 6 - Rumor -3
